nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Activation of nicotinic acetylcholine receptor α7 subunit limits Zika viral infection via promoting autophagy and ferroptosis
|
Zhao, Caiqi |
|
|
32 |
8 |
p. 2641-2661 |
artikel |
2 |
An aptamer-mediated base editing platform for simultaneous knockin and multiple gene knockout for allogeneic CAR-T cells generation
|
Porreca, Immacolata |
|
|
32 |
8 |
p. 2692-2710 |
artikel |
3 |
Bispecific antibodies and autologous chimeric antigen receptor T cell therapies for treatment of hematological malignancies
|
Al Hadidi, Samer |
|
|
32 |
8 |
p. 2444-2460 |
artikel |
4 |
Building a novel TRUCK by harnessing the endogenous IFN-gamma promoter for cytokine expression
|
Ma, Liya |
|
|
32 |
8 |
p. 2728-2740 |
artikel |
5 |
Can self-amplifying RNA vaccines and viruses exchange genetic material?
|
Casmil, Irafasha C. |
|
|
32 |
8 |
p. 2437-2438 |
artikel |
6 |
Clinical perspectives: Treating spinal muscular atrophy
|
McPheron, Molly A. |
|
|
32 |
8 |
p. 2489-2504 |
artikel |
7 |
CRISPR-mediated Sox9 activation and RelA inhibition enhance cell therapy for osteoarthritis
|
Zhao, Lan |
|
|
32 |
8 |
p. 2549-2562 |
artikel |
8 |
Decoding the specificity of m6A RNA methylation and its implication in cancer therapy
|
Cun, Yixian |
|
|
32 |
8 |
p. 2461-2469 |
artikel |
9 |
Dedifferentiation-like reprogramming of degenerative nucleus pulposus cells into notochordal-like cells by defined factors
|
Zhang, Yuang |
|
|
32 |
8 |
p. 2563-2583 |
artikel |
10 |
Dual FKRP/FST gene therapy normalizes ambulation, increases strength, decreases pathology, and amplifies gene expression in LGMDR9 mice
|
Lam, Patricia |
|
|
32 |
8 |
p. 2604-2623 |
artikel |
11 |
Harnessing extracellular vesicles for pancreatic fibrosis therapy
|
Bobis-Wozowicz, Sylwia |
|
|
32 |
8 |
p. 2441-2443 |
artikel |
12 |
Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing
|
Hill, Tyler F. |
|
|
32 |
8 |
p. 2676-2691 |
artikel |
13 |
In this issue
|
|
|
|
32 |
8 |
p. 2429 |
artikel |
14 |
In vivo genome editing for inherited retinal disease: Opportunities and challenges
|
Collin, Rob W.J. |
|
|
32 |
8 |
p. 2433-2434 |
artikel |
15 |
In vivo mRNA expression of a multi-mechanistic mAb combination protects against Staphylococcus aureus infection
|
Tkaczyk, Christine |
|
|
32 |
8 |
p. 2505-2518 |
artikel |
16 |
In vivo selection in non-human primates identifies AAV capsids for on-target CSF delivery to spinal cord
|
Hanlon, Killian S. |
|
|
32 |
8 |
p. 2584-2603 |
artikel |
17 |
lnc-Rps4l-encoded peptide RPS4XL regulates RPS6 phosphorylation and inhibits the proliferation of PASMCs caused by hypoxia
|
Li, Yiying |
|
|
32 |
8 |
p. 2799 |
artikel |
18 |
Molecular Therapy’s growing influence
|
Herzog, Roland W. |
|
|
32 |
8 |
p. 2427 |
artikel |
19 |
Newly developed oral bioavailable EHMT2 inhibitor as a potential epigenetic therapy for Prader-Willi syndrome
|
Wang, Sung Eun |
|
|
32 |
8 |
p. 2662-2675 |
artikel |
20 |
NKG2A genetic deletion promotes human primary NK cell anti-tumor responses better than an anti-NKG2A monoclonal antibody
|
Gong, Ying |
|
|
32 |
8 |
p. 2711-2727 |
artikel |
21 |
Optimized rAAV8 targeting acinar KLF4 ameliorates fibrosis in chronic pancreatitis via exosomes-enriched let-7s suppressing pancreatic stellate cells activation
|
Zhao, Yating |
|
|
32 |
8 |
p. 2624-2640 |
artikel |
22 |
Overcoming effector T cell exhaustion in ovarian cancer ascites with a novel adenovirus encoding for a MUC1 bispecific antibody engager and IL-2 cytokine
|
Basnet, Saru |
|
|
32 |
8 |
p. 2800 |
artikel |
23 |
PDIA3 orchestrates effector T cell program by serving as a chaperone to facilitate the non-canonical nuclear import of STAT1 and PKM2
|
Yang, Chun-Liang |
|
|
32 |
8 |
p. 2778-2797 |
artikel |
24 |
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification
|
Cortese, Marco |
|
|
32 |
8 |
p. 2741-2761 |
artikel |
25 |
Preclinical evidence in the assembly of mammalian SWI/SNF complexes: Epigenetic insights and clinical perspectives in human lung disease therapy
|
Trejo-Villegas, Octavio A. |
|
|
32 |
8 |
p. 2470-2488 |
artikel |
26 |
RNA therapeutics targeting PD-L1 is a promising immune-activation strategy against difficult-to-treat cancers
|
Ding, Li |
|
|
32 |
8 |
p. 2439-2440 |
artikel |
27 |
Safety concern of recombination between self-amplifying mRNA vaccines and viruses is mitigated in vivo
|
Hick, Tessy A.H. |
|
|
32 |
8 |
p. 2519-2534 |
artikel |
28 |
Targeting PD-L1 in cholangiocarcinoma using nanovesicle-based immunotherapy
|
Gondaliya, Piyush |
|
|
32 |
8 |
p. 2762-2777 |
artikel |
29 |
The first medical education program on gene and gene-modified cell therapies for Latin America
|
Alméciga-Díaz, Carlos Javier |
|
|
32 |
8 |
p. 2430-2432 |
artikel |
30 |
The tricky second album: Licensure of an mRNA vaccine for respiratory syncytial virus
|
Tregoning, John S. |
|
|
32 |
8 |
p. 2428 |
artikel |
31 |
Thymidylate synthase disruption to limit cell proliferation in cell therapies
|
Sartori-Maldonado, Rocio |
|
|
32 |
8 |
p. 2535-2548 |
artikel |
32 |
Transforming care for spinal muscular atrophy: A critical look at treatment paradigms
|
Veerapandiyan, Aravindhan |
|
|
32 |
8 |
p. 2435-2436 |
artikel |
33 |
Valproic Acid Confers Functional Pluripotency to Human Amniotic Fluid Stem Cells in a Transgene-free Approach
|
Moschidou, Dafni |
|
|
32 |
8 |
p. 2798 |
artikel |